{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:03:36Z","timestamp":1789625016695,"version":"build-2803163510"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To comprehensively assess the clinical effectiveness of probiotic supplementation in individuals with diabetic nephropathy (DN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Randomized controlled trials (RCTs) evaluating probiotics for DN were retrieved from eight databases from inception to January 2026. Data on study characteristics, outcome measures, and risk of bias were independently extracted. Meta-analyses were conducted using Review Manager version 5.3, while trial sequential analysis (TSA) was performed with TSA version 0.9.5.10 beta. Potential publication bias was examined using Egger\u2019s regression test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine RCTs encompassing 644 participants met the inclusion criteria. Pooled analyses indicated that probiotic supplementation was associated with significant reductions in serum creatinine (mean difference [MD] \u22120.10\u202fmg\/dL, 95% confidence interval [CI] \u22120.14 to \u22120.06), blood urea nitrogen (BUN) (MD\u202f\u2212\u202f2.76\u202fmg\/dL, 95% CI\u202f\u2212\u202f5.40 to \u22120.11), fasting plasma glucose (MD\u202f\u2212\u202f0.63\u202fmmol\/L, 95% CI\u202f\u2212\u202f0.80 to \u22120.46), 2-h postprandial blood glucose (2\u202fh PBG) (MD\u202f\u2212\u202f0.66%\u202fmmol\/L, 95% CI \u22121.10 to \u22120.22), glycated hemoglobin (HbA1c) (MD \u22120.40%, 95% CI \u22120.72 to \u22120.09), triglycerides (MD \u221219.17\u202fmg\/dL, 95% CI \u221235.14 to \u22123.20), total cholesterol (MD \u221211.68\u202fmg\/dL, 95% CI \u221220.37 to \u22122.99), low-density lipoprotein cholesterol (MD \u221212.72\u202fmg\/dL, 95% CI \u221218.76 to \u22126.67), high-sensitivity C-reactive protein (MD \u22121.69\u202fmg\/L, 95% CI \u22122.38 to \u22121.00), and malondialdehyde (MD\u202f\u2212\u202f0.52\u202f\u03bcmol\/L, 95% CI \u22120.91 to \u22120.13). However, no statistically significant improvements were detected in estimated glomerular filtration rate, 24-h urinary protein excretion, insulin levels, high-density lipoprotein cholesterol, or total antioxidant capacity. TSA supported the reliability of all significant findings except for BUN and triglycerides. Egger\u2019s test revealed no evidence of publication bias for most outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Probiotics reduce circulating inflammation and oxidative stress levels in patients with DN, highlighting their potential as an adjunctive therapy, although their effects on glycolipid metabolism and kidney function appear to be modest. Nevertheless, given the limitations of small sample sizes and regional concentration, these findings warrant further validation through multicenter RCTs involving diverse ethnic populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      The systematic review was prospectively registered in PROSPERO (CRD420261375372). The registration is publicly accessible at\n                      <jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:uri>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1863111","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:31:17Z","timestamp":1789623077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical value of probiotics as adjunctive therapy for diabetic nephropathy: a meta-analysis and trial sequential analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiangning","family":"Huang","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Endocrine, The First Hospital of Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Endocrine, The First Hospital of Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, China"]},{"name":"Department of Endocrine, The First Hospital of Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mcna.2023.03.004","article-title":"Diabetic kidney disease: an update","volume":"107","author":"Gupta","year":"2023","journal-title":"Med Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002146","article-title":"Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK","volume":"9","author":"Gonz\u00e1lez-P\u00e9rez","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref3","volume-title":"USRDS Annual data Report: Epidemiology of Kidney Disease in the United States","year":"2025"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/CM9.0000000000003428","article-title":"Epidemiological status, development trends, and risk factors of disability-adjusted life years due to diabetic kidney disease: a systematic analysis of global burden of disease study 2021","volume":"138","author":"Li","year":"2025","journal-title":"Chin Med J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-025-01171-3","article-title":"Mechanisms of diabetic kidney disease and established and emerging treatments","volume":"22","author":"Martinez Leon","year":"2026","journal-title":"Nat Rev Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.3390\/ijms25063086","article-title":"Recent advances in the management of diabetic kidney disease: slowing progression","volume":"25","author":"Wang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/ANNALS-24-01926","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2024 clinical practice guideline","volume":"178","author":"Madero","year":"2025","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.kint.2022.06.013","article-title":"Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence","volume":"102","author":"Rossing","year":"2022","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/diagnostics15010021","article-title":"The gut\u2013kidney axis in chronic kidney diseases","volume":"15","author":"Tsuji","year":"2024","journal-title":"Diagnostics"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s10020-023-00745-z","article-title":"The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease","volume":"29","author":"Ma","year":"2023","journal-title":"Mol Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2473506","DOI":"10.1080\/19490976.2025.2473506","article-title":"Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease","volume":"17","author":"Wu","year":"2025","journal-title":"Gut Microbes"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1681\/ASN.2021060843","article-title":"Intestinal bacterial translocation contributes to diabetic kidney disease","volume":"33","author":"Linh","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/s41598-023-39444-4","article-title":"Alterations of gut microbiota in biopsy-proven diabetic nephropathy and a long history of diabetes without kidney damage","volume":"13","author":"Lu","year":"2023","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41591-018-0164-x","article-title":"Regional variation limits applications of healthy gut microbiome reference ranges and disease models","volume":"24","author":"He","year":"2018","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1287698","DOI":"10.3389\/fimmu.2023.1287698","article-title":"Genetic evidence supporting the causal role of gut microbiota in chronic kidney disease and chronic systemic inflammation in CKD: a bilateral two-sample Mendelian randomization study","volume":"14","author":"Ren","year":"2023","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1124704","DOI":"10.3389\/fimmu.2023.1124704","article-title":"Gut microbiota and its metabolites \u2013 molecular mechanisms and management strategies in diabetic kidney disease","volume":"14","author":"Mao","year":"2023","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.7150\/thno.84650","article-title":"Outer membrane vesicles derived from gut microbiota mediate tubulointerstitial inflammation: a potential new mechanism for diabetic kidney disease","volume":"13","author":"Chen","year":"2023","journal-title":"Theranostics"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1007\/s00394-020-02207-2","article-title":"Effect of probiotics on the intestinal microbiota of hemodialysis patients: a randomized trial","volume":"59","author":"Liu","year":"2020","journal-title":"Eur J Nutr"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1729409","DOI":"10.3389\/fmicb.2025.1729409","article-title":"Clinical efficacy of probiotics in the treatment of diabetes kidney disease: a systematic review and meta-analysis","volume":"16","author":"Liu","year":"2026","journal-title":"Front Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2174\/1871530321666210121154037","article-title":"Can probiotics supplementation improve glycemic and renal status in diabetic nephropathy? A systematic review and meta-analysis of clinical trials","volume":"22","author":"Tarrahi","year":"2022","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e05925","DOI":"10.1016\/j.heliyon.2021.e05925","article-title":"Effect of probiotics on oxidative stress and inflammatory status in diabetic nephropathy: a systematic review and meta-analysis of clinical trials","volume":"7","author":"Bohlouli","year":"2021","journal-title":"Heliyon"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1080\/0886022X.2022.2079522","article-title":"Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis","volume":"44","author":"Dai","year":"2022","journal-title":"Ren Fail"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clnesp.2020.06.019","article-title":"Efficacy of probiotic supplementation in patients with diabetic nephropathy: a systematic review and meta-analysis","volume":"40","author":"AbdelQadir","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40200-021-00765-8","article-title":"The effect of probiotics on lipid profile and anthropometric indices in diabetic nephropathy; a systematic review and meta-analysis of clinical trials","volume":"20","author":"Moravejolahkami","year":"2021","journal-title":"J Diabetes Metab Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/10408398.2020.1740645","article-title":"Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"61","author":"Zheng","year":"2021","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1166\/mex.2021.1888","article-title":"The effects of probiotic supplementation on renal function, inflammation, and oxidative stress in diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Wang","year":"2021","journal-title":"Mater Express"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.23751\/pn.v20i2-S.5342","article-title":"Effects of probiotic soy milk on lipid panel in type 2 diabetic patients with nephropathy: a double-blind randomized clinical trial","volume":"20","author":"Abbasi","year":"2018","journal-title":"Prog Nutr"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s12602-018-9468-x","article-title":"The effects of probiotic honey consumption on metabolic status in patients with diabetic nephropathy: a randomized, double-blind, controlled trial","volume":"11","author":"Arani","year":"2019","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12906-015-0952-5","article-title":"Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial","volume":"15","author":"Firouzi","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.16658\/j.cnki.1672-4062.2022.16.034","article-title":"Effect of dapagliflozin combined with probiotics on inflammatory markers, blood glucose, and renal function in diabetic nephropathy patients","volume":"25","author":"Guan","year":"2022","journal-title":"Diabetes New World"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e23650","DOI":"10.1002\/jcla.23650","article-title":"Probiotics ameliorates glycemic control of patients with diabetic nephropathy: a randomized clinical study","volume":"35","author":"Jiang","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.3969\/j.issn.1671-8348.2024.20.007","article-title":"Effect of synergistic action of probiotics and lactulose on gastrointestinal motility, mucosal function, and disease progression in elderly patients with type 2 diabetic kidney disease and constipation","volume":"53","author":"Lu","year":"2024","journal-title":"Chongqing Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1039\/C8FO00888D","article-title":"Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial","volume":"9","author":"Mafi","year":"2018","journal-title":"Food Funct"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1053\/j.jrn.2017.04.004","article-title":"The impact of probiotic soy milk consumption on oxidative stress among type 2 diabetic kidney disease patients: a randomized controlled clinical trial","volume":"27","author":"Miraghajani","year":"2017","journal-title":"J Ren Nutr"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.13381\/j.cnki.cjm.202005016","article-title":"Effect of probiotic supplementation on disease progression risk in elderly patients with diabetic kidney disease","volume":"32","author":"Tang","year":"2020","journal-title":"Chin J Microecol"},{"key":"ref37","volume-title":"Clinical Methods: the History, Physical, and Laboratory Examinations","author":"Hosten","year":"1990"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism","volume":"80","author":"Wyss","year":"2000","journal-title":"Physiol Rev"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2211917","DOI":"10.1080\/19490976.2023.2211917","article-title":"The infant gut microbiota: in pursuit of non-protein nitrogen","volume":"15","author":"Schimmel","year":"2023","journal-title":"Gut Microbes"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e1004472","DOI":"10.1371\/journal.ppat.1004472","article-title":"Microbial urease in health and disease","volume":"10","author":"Mora","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/biology14060723","article-title":"Gut microbiome engineering for diabetic kidney disease prevention: a lactobacillus rhamnosus GG intervention study","volume":"14","author":"Qumsani","year":"2025","journal-title":"Biology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.kint.2016.09.040","article-title":"Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects","volume":"91","author":"Soleimani","year":"2017","journal-title":"Kidney Int"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tim.2022.08.003","article-title":"Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease","volume":"31","author":"Jia","year":"2023","journal-title":"Trends Microbiol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1017\/S095442241700018X","article-title":"Probiotics, prebiotics, synbiotics and insulin sensitivity","volume":"31","author":"Kim","year":"2018","journal-title":"Nutr Res Rev"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"106520","DOI":"10.1016\/j.phrs.2022.106520","article-title":"The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: a systematic review, meta-analysis, and meta-regression of clinical trials","volume":"185","author":"Paul","year":"2022","journal-title":"Pharmacol Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/nu16162677","article-title":"Comparison of glucose metabolizing properties of enterobacterial probiotic strains in vitro","volume":"16","author":"Balanche","year":"2024","journal-title":"Nutrients"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1475-2891-13-60","article-title":"Gut microbiota, probiotics and diabetes","volume":"13","author":"Gomes","year":"2014","journal-title":"Nutr J"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.2337\/dci24-0052","article-title":"The gut microbiota and diabetes: research, translation, and clinical applications\u20142023 diabetes, diabetes care, and diabetologia expert forum","author":"Byndloss","year":"2024","journal-title":"Diabetes Care"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4093\/dmj.2021.0329","article-title":"Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease","volume":"46","author":"Jung","year":"2022","journal-title":"Diabetes Metab J"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"24705470221076390","DOI":"10.1177\/24705470221076390","article-title":"The role of lipopolysaccharide-induced cell signalling in chronic inflammation","volume":"6","author":"Page","year":"2022","journal-title":"Chronic Stress"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/antiox13040455","article-title":"Oxidative stress: a culprit in the progression of diabetic kidney disease","volume":"13","author":"Wang","year":"2024","journal-title":"Antioxidants"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1756283X12459294","article-title":"Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation","volume":"6","author":"Hemarajata","year":"2013","journal-title":"Ther Adv Gastroenterol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2022407","DOI":"10.1080\/19490976.2021.2022407","article-title":"Epigenetic regulation by gut microbiota","volume":"14","author":"Woo","year":"2022","journal-title":"Gut Microbes"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"H839","DOI":"10.1152\/ajpheart.00278.2021","article-title":"Lactobacillus plantarum probiotic induces Nrf2-mediated antioxidant signaling and eNOS expression resulting in improvement of myocardial diastolic function","volume":"321","author":"Aboulgheit","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/biomedicines9101340","article-title":"Biomarkers and utility of the antioxidant potential of probiotic lactobacilli and bifidobacteria as representatives of the human gut microbiota","volume":"9","author":"Averina","year":"2021","journal-title":"Biomedicine"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"m4743","DOI":"10.1136\/bmj.m4743","article-title":"Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data","volume":"372","author":"Goldenberg","year":"2021","journal-title":"BMJ"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1669636","DOI":"10.3389\/fphar.2025.1669636","article-title":"Comparison of short-term and long-term renal function effects of vasopressin and norepinephrine in patients with septic shock: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2025","journal-title":"Front Pharmacol"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1863111\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:31:21Z","timestamp":1789623081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1863111\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":58,"alternative-id":["10.3389\/fnut.2026.1863111"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1863111","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1863111"}}